Showing results (71-80 of 210) with videos related to

Sort By:
Pageof 21
Autoimmunity Reviews|August 17, 2018
Childhood- versus Adult-Onset Polyarteritis Nodosa Results from the French Vasculitis Study Group RegistryMichele Iudici, Pierre Quartier, Christian Pagnoux, et al.
Annals of the Rheumatic Diseases|December 25, 2017
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitisPierre Quartier, Amandine Baptiste, Véronique Despert, et al.
BMC Pharmacology & Toxicology|August 7, 2013
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromesSaik Urien, Christophe Bardin, Brigitte Bader-Meunier, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Pediatric Rheumatology Online Journal|April 4, 2018
Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centreMaxime Goirand, Sylvain Breton, Frédéric Chevallier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatmentPierre Quartier, Olivier Tournilhac, Christine Archimbaud, et al.
American Journal of Medical Genetics. Part A|June 9, 2012
Progressive polyepiphyseal dysplasia with arthropathy: a distinct disorder from idiopathic juvenile arthritis and pseudorheumatoid dysplasia?Bertrand Isidor, Sylvaine Poignant, Georges Picherot, et al.
The New England Journal of Medicine|June 5, 2009
Use of canakinumab in the cryopyrin-associated periodic syndromeHelen J Lachmann, Isabelle Kone-Paut, Jasmin B Kuemmerle-Deschner, et al.
The Journal of Rheumatology|June 17, 2011
Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9 patients from the French Autoimmunity and Rituximab registryBrigitte Bader-Meunier, Hélène Decaluwe, Christine Barnerias, et al.
Pediatric Rheumatology Online Journal|September 4, 2021
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practiceJulie Molimard, Christine Pajot, Priscille Olle, et al.
Pageof 21